Latest News about Biogen Inc
Recent news which mentions Biogen Inc
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
From CNBC.com News
5 things to know before the stock market opens Monday
February 10, 2025
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
From CNBC.com News
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
From CNBC.com News
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
From CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
From CNBC.com News